Astrazeneca Pharma India Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 11,322 shares,. Its Average Traded Price (ATP) is ₹6095.90, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹6113.00.
Astrazeneca Pharma India has an upper circuit limit of ₹7252.00 and a lower circuit limit of ₹4835.00. The total value traded stands at ₹6.90 CR, and the delivery percentage for the day is 35.52%.
The stock is currently traded with a market lot size of 1. Astrazeneca Pharma India also offers a dividend yield of 0%.
Astrazeneca Pharma India Share Price Chart
Astrazeneca Pharma India Share Key Metrics
Volume
11322.00
Market Cap
15282.50 CR
LTQ@LTP
1@6113.00
ATP
6095.9
Var Margin
14.71 %
Circuit Range
4835-7252
Delivery %
35.52 %
Value
6.90 CR
ASM/GSM
No
Market Lot
1
Astrazeneca Pharma India Resistance and Support
Pivot 6141.67
Resistance
First Resistance
6301.84
Second Resistance
6560.17
Third Resistance
6720.34
Support
First Support
5883.34
Second Support
5723.17
Third Support
5464.84
Astrazeneca Pharma India Shareholding Pattern
View More- 2016-17
- 2018-19
- 2017-18
- 2019-20
- 2020-21
- 2024-25
- 2021-22
- 2022-23
- 2023-24
- 2025-26
- 2026-27
Total Promoters
Astrazeneca Pharma India Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-05 | Quarterly Results |
| 2026-08-10 | Quarterly Results |
| 2026-05-26 | Audited Results & Final Dividend |
| 2026-02-11 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-08-14 | Quarterly Results |
| 2025-05-30 | Audited Results & Dividend |
| 2025-02-11 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-07-31 | 2026-07-31 | View More |
Astrazeneca Pharma India News
AstraZeneca Pharma India Ltd - 506820 - Revised Submission With Functional Link - Letter Of Intent With Strand Life Sciences Private Limited - Disclosure Of Linkedin Communication
AstraZeneca Pharma has signed a Letter of Intent with Strand Life Sciences Private Limited, a subsidiary of Reliance Industries Limited. The partnership aims to explore opportunities to collaborate in healthcare in India.
Nov 17 2026 15:16:39
AstraZeneca Pharma India Ltd - 506820 - Letter Of Intent With Strand Life Sciences Private Limited - Disclosure Of Linkedin Communication
AstraZeneca Pharma signed an LOI with Strand Life Sciences, a subsidiary of Reliance Industries. The partnership aims to explore healthcare collaboration opportunities in India.
Nov 17 2026 14:00:41
AstraZeneca Pharma India Ltd - 506820 - Launch Of Datopotamab Deruxtecan (Brand Name: Datverzo)
AstraZeneca Pharma India will launch its breast cancer treatment drug Datverzo in India in November 2026. The drug is approved for adult patients with unresectable or metastatic HR-positive, HER2-negative breast cancer who have received prior therapy.
Nov 07 2026 12:19:19
AstraZeneca Pharma India Ltd - 506820 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
AstraZeneca Pharma announced Q2 FY27 revenue of Rs.729 crore, a 30% YoY growth, driven by its oncology portfolio. The company also received three new regulatory approvals and signed MoUs with AP and Telangana for cancer screening initiatives.
Nov 05 2026 19:34:40
AstraZeneca Pharma India Ltd - 506820 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday, November 5, 2026
AstraZeneca Pharma reported strong Q2 FY27 results with total income rising 31.6% YoY to ₹744.22 crores and net profit up 15% YoY to ₹62.33 crores. The board also approved major leadership changes, including the appointment of Atul Tandon as Chief Financial Officer.
Nov 05 2026 17:37:47
AstraZeneca Pharma India Ltd - 506820 - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Thursday, November 5, 2026
AstraZeneca Pharma board to meet on 5 Nov 2026 for financial results.
Oct 30 2026 14:38:14
Astrazeneca Pharma India Management
| Name | Position |
|---|---|
| Shilpa Divekar Nirula | Chairperson |
| Revathy Ashok | Non Executive Independent Director |
Astrazeneca Pharma India Similar Stocks
Piramal Pharma Ltd.
239.65
0.70 (0.29%)
Rubicon Research Ltd.
1722.30
64.00 (3.86%)
Neuland Laboratories Ltd.
21125.00
-330.00 (1.54%)
Granules India Ltd.
801.20
3.70 (0.46%)
Alembic Pharmaceuticals Ltd.
1049.60
5.25 (0.50%)
Eris Lifesciences Ltd.
1321.50
-15.60 (1.17%)
Onesource Specialty Pharma Ltd.
1602.90
16.70 (1.05%)
Shilpa Medicare Ltd.
900.70
-14.60 (1.60%)
Pfizer Ltd.
3850.30
8.50 (0.22%)
Cohance Lifesciences Ltd.
459.75
3.35 (0.73%)
Astrazeneca Pharma India FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in ASTRAZEN
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC